Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

53 results about "Treatment interval" patented technology

Treatment Intervals: Treatment Interval recommendations are a general guideline only and are a compilation of intervals used. by successful operators. Facial hair: 6-8 week intervals between treatments.

Suture-based systems and methods for treating septal defects

A system for treating a septal defect having a suture-like implantable treatment apparatus and devices for delivering the implantable treatment apparatus and methods for treating a septal defect are provided. The suture-like apparatus is preferably implantable through a septal wall or portion thereof. The treatment system can include a flexible elongate body member, a delivery device configured to deliver the suture-like apparatus, a stabilization device configured to stabilize the delivery device and a positioning device configured to position the delivery device in a desired location. The suture-like device can include a suture body coupled with one or more lock devices or anchor devices.
Owner:PROMED

Systems and methods for treating septal defects

A system for treating a septal defect having an implantable treatment apparatus and devices for delivering the implantable treatment apparatus and methods for treating a septal defect are provided. The implantable treatment apparatus is preferably implantable through a septal wall or portion thereof. The treatment system can include a flexible elongate body member, a delivery device configured to deliver the implantable apparatus, a stabilization device configured to stabilize the body member and a positioning device configured to position the delivery device in a desired location.
Owner:OVALIS

Stimulus regimens for cardiovascular reflex control

InactiveUS20070049989A1Modulate activityModulation of the reflex control of the patient's circulationStentsSpinal electrodesElectricityControl signal
Baroreflex activation is achieved by providing suitable control signals to a baroreflex activation device. A method comprises establishing a therapy interval (possibly on the order of minutes to hours, or possibly of indefinite duration), within the therapy interval, establishing a plurality of dose intervals, and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of at least some dose intervals. Another method comprises establishing a series of therapy interval portions, during at least some therapy intervals, establishing a plurality of burst intervals (perhaps having durations commensurate with an interval between heartbeats), and generating an electrical output signal. The electrical output signal has a time dependence such that the average electrical power applied to the baroreflex activation device differs between first and second portions of the therapy intervals and also differs between first and second portions of at least some burst intervals.
Owner:CVRX

Patch for treating a septal defect

A system for treating a septal defect comprises a treatment device slidably received within a catheter. The device includes a patch attached to a support. The support has a body segment and a plurality of leg segments that self-expand radially outward as the device is released from the catheter. A method for treating a septal defect comprises delivering the treatment device in the catheter proximate a septal defect. The device is slid in a distal direction to release a portion of each leg segment from the catheter, the leg segments partially expanded radially outward. The leg segments are placed in contact with tissue surrounding the septal defect. The device is slid farther until the leg segments are fully released from the catheter and fully expanded, thereby implanting a distal portion of each leg segment in tissue surrounding the septal defect and positioning the patch against the septal defect.
Owner:METRONIC VASCULAR

Transdermal delivery

Dosing regimen for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval.
Owner:AGILE THERAPEUTICS

Multi-modal operation of a medical device system

Apparatuses and methods support multi-modal operation of a medical device system for a nervous system disorder. The medical device system comprises an implanted component and an external component and supports a first feature and a second feature that are associated with the treatment therapy. The medical device system supports both features when the implanted component and the external component are coupled. If the external component is decoupled, the implanted component continues to support the first feature. Moreover, the embodiment may support a plurality of features during a treatment interval. Another aspect of the invention allows for modularly expanding a medical device system in order to add a feature that enhances existing functionality or that provides additional functionality. In an embodiment, a module that is associated with an external component of the medical device system supports the added feature.
Owner:MEDTRONIC INC

Methods for treating ocular diseases

A method is provided for reducing the treatment burden for patients who have an intraocular neovascular disorder, the method comprising administering a therapeutically effective amount of VEGF antagonist on a dosing schedule that includes treatment intervals of 8 and / or 12 weeks.
Owner:NOVARTIS AG

Bone treatment systems and methods

Systems and methods for treating vertebral compression fractures are provided. A kit can include at least one body containing a bone cement precursor to be mixed with at least one other bone cement precursor to form a bone cement. The body or a package containing the body can include at least one sensor. In some embodiments the sensor can be a temperature sensor. In some methods, data from the sensor can be used to determine certain parameters related to a treatment interval involving the bone cement.
Owner:DFINE INC

Systems, methods and devices for endometrial ablation utilizing radio frequency

Methods, systems and devices for endometrial ablation. In accordance with a method, a working end of an RF ablation device is positioned in a patient uterus to contact endometrial tissue, the working end comprising a dielectric. Radiofrequency energy is applied for a first interval of time at constant power, the power being sufficient to capacitively couple current across the dielectric to the contacted endometrial tissue. A voltage parameter measured within the first interval, and radiofrequency energy is applied at a constant voltage over a second, treatment interval to ablate endometrial tissue, the constant voltage being related to the recorded voltage.
Owner:MINERVA SURGICAL

Method and Device for Thermal Breast Tumor Treatment with 3D Monitoring Function

An X-ray machine for monitoring thermal treatment of human tissue produces a reference exposure of the tissue to be treated prior to commencement of the treatment. Thermal treatment is performed subsequently. Check exposures are made with the X-ray machine during the treatment or also during treatment intervals. The check exposures are performed as partial volume exposures at a lower radiation load than the reference exposures. From a comparison of check exposures with the reference exposures, conclusions can be drawn concerning changes of tissue temperature and also tissue properties.
Owner:AB CT ADVANCED BREAST CT GMBH

Data processing and communication unit for recording patient data in therapy-free intervals

A patient data monitoring system is disclosed for central monitoring of vital parameters of at least one dialysis patient in a therapy-free interval. The system includes a central patient database for storing patient data, at least one measuring device carried along or kept at home by a patient during the therapy-free interval, and a portable data processing and communication device carried along or kept at home by the patient in the therapy-free interval that assigns a corresponding patient ID to each measured vital parameter received from the at least one measuring device via data communication, automatically sets up a remote data connection to the central patient database and, once the connection to the central patient database is set up, automatically transmits a data set including patient ID and the at least one measured vital parameter to the central patient database.
Owner:B BRAUN AVITUM

Forming conductive arch channels in subterranean formation fractures

Methods including introducing a pad fluid into a subterranean formation to create or enhance an open fracture at a first treatment interval therein; introducing a treatment fluid into the fracture, wherein the treatment fluid comprises a second base fluid, crushable-proppant particulates (CPPs), and buoyant-proppant particulates (BPPs), and wherein a first specific gravity of the CPPs is at least about 0.3 greater than a second specific gravity of the BPPs; placing the CPPs and the BPPs in the fracture, wherein the CPPs settle to a bottom portion of the fracture and the BPPs neutrally suspend in the treatment fluid in a top portion of the fracture; and reducing the hydraulic pressure, thereby permitting the fracture to close, wherein the CPPs form a crushed-proppant pack in the bottom portion of the fracture and the BPPs form a proppant pack in the top portion of the fracture, thereby forming an arch channel therebetween.
Owner:HALLIBURTON ENERGY SERVICES INC

Generating and enhancing microfracture conductivity

Methods comprising: introducing a micro-proppant treatment fluid into a formation at a rate and pressure sufficient to create or enhance at least one fracture in a first treatment interval, wherein the micro-proppant treatment fluid comprises a first aqueous base fluid, micro-proppant particulates, and a first aqueous-based surface modification agent (“ASMA”); placing the micro-proppant particulates into the at least one fracture; introducing a surface modification treatment fluid into the subterranean formation, wherein the surface modification treatment fluid comprises a second aqueous base fluid and a second ASMA; coating at least a portion of a face of the at least one fracture with the second ASMA; introducing a macro-proppant treatment fluid into the subterranean formation, wherein the macro-proppant treatment fluid comprises a third base fluid and macro-proppant particulates; and placing the macro-proppant particulates into the at least one fracture.
Owner:HALLIBURTON ENERGY SERVICES INC

Isoflavones compound and preparation and application thereof

The invention discloses a novel isoflavones compound as shown by a formula I. The results of animal experiments show that the isoflavones compound can significantly inhibit the proliferation of T cells and B cells, and can be used for preparing immunosuppressants or medicaments for treating immunologic diseases. The SI values (IC50 / CC50) of the isoflavones compound are high, so the toxic side effects of the isoflavones compound are small, and the treatment interval of the isoflavones compound is wide. The isoflavones compound is obtained by extracting and separating clovershrubs, and the preparation method is simple and convenient.
Owner:BASILEA PHARM CHINA LTD

Remote unattended low level light therapy orthopedic device, wearing means and method of use

A new and useful portable remote unattended low level light therapy (“LLLT”) orthopedic device that is lightweight, programmable, portable, affordable, able to be worn passively by the patient, able to operate unattended by a practitioner or physician, and can be used to administer multiple and / or extended treatment intervals outside the office setting. The device comprises a light therapy circuit with a power supply, controller circuit, LED driver circuit and an array of near infrared LEDs. Additionally the device comprises mode indicators and a program receiving port for programming by an external programming means. The entirety of the electrical components of the device are enclosed in a circuit housing and attached to a wearing means or brace. En toto, the device is used to direct low level light towards an indicated part of a patients anatomy in the field or orthopedic therapy.
Owner:GRASSO IV LOUIS

System and method for treating septal defects

A system for introducing and advancing medical devices into vessels, including an introducer with a first elongated tubular member having a first connection element at a distal end and a guide catheter comprising a second connection element at a proximal end, the first and second elongated tubular members being substantially hollow for receiving and passing through an expandable device for treatment of septal defects, where the first connection element includes a female connection element with an internal continuous annularly shaped protruding rib; and the second connection element comprises a male connection element adapted to be inserted into the first connection element, the second connection element having an external continuous annularly shaped protruding rib, where the internal rib and external rib are configured to interlock and resist relative longitudinal movement while allowing relative rotational movement. Methods of making and using are also described as well as an associated cutting apparatus.
Owner:MINNESOTA MEDTEC INC

Community diagnosis and treatment reservation service system

InactiveCN108831545AReduce workloadAvoid the problem of not being able to see the doctor at the appropriate timeReservationsHealthcare resources and facilitiesDiseaseTreatment interval
The invention provides a community diagnosis and treatment reservation service system, which is characterized by comprising at least one site terminal and a center management device. A patient information storage part is used to store patient information of patients and corresponding disease types. An interval storage part stores multiple disease types and corresponding diagnosis and treatment intervals. A reservation control part controls a retrieval and acquisition part to retrieve the patient information storage part according to the received patient information to acquire a disease type ofthe corresponding patient and retrieve the interval storage part to acquire a corresponding diagnosis and treatment interval according to the disease type, controls a consultation time calculation part to calculate a next needed consultation date of the patient based on the diagnosis and treatment interval and the current date, controls the retrieval and acquisition part to retrieve a reservationrecord storage part according to the needed consultation date to acquire a reservation record of a doctor in the needed consultation date and further controls a center-side communication part to senda retrieved reservation record to the site terminal, and thus, the doctor selects a reservation time period.
Owner:上海市杨浦区大桥社区卫生服务中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products